Table 2.
Clinical characteristics of patients.
| Characteristics | CAD | ACS |
|---|---|---|
| (N = 50) | (N = 20) | |
| Age (years) | 70 ± 7 | 65 ± 11 |
| Sex (male/female) | 40/10 | 19/1 |
| Risk factors | ||
| Family history, n (%) | 13 (26) | 6 (30) |
| Hypertension, n (%) | 38 (76) | 12 (60) |
| Diabetes, n (%) | 21 (42) | 5 (25) |
| Smoking, n (%) | 35 (70) | 13 (65) |
| Body mass index | 24.5 ± 3.7 | 24.1 ± 2.5 |
| Systolic BP (mm Hg) | 138 ± 19 | 139 ± 25 |
| Diastolic BP (mm Hg) | 78 ± 12 | 81 ± 17 |
| Laboratory measurements | ||
| TC (mg/dL) | 165 ± 28 | 189 ± 44∗ |
| TG (mg/dL) | 120 ± 48 | 155 ± 106∗ |
| LDL cholesterol (mg/dL) | 96 ± 26 | 114 ± 34∗ |
| HDL cholesterol (mg/dL) | 45 ± 13 | 48 ± 10 |
| Creatinine (mg/dL) | 0.84 ± 0.22 | 0.77 ± 0.26 |
| HbA1c (%) | 5.8 ± 0.7 | 5.7 ± 0.8 |
| Hs-CRP (mg/dL) | 0.12 ± 0.16 | 0.13 ± 0.07 |
| BNP (pg/mL) | 57 ± 72 | 89 ± 121 |
| Medications, n (%) | ||
| Antiplatelet | 50 (100) | 20 (100) |
| β-blocker | 24 (48) | 6 (30) |
| ACEI/ARB | 27 (54) | 11 (55) |
| CCB | 23 (46) | 6 (30) |
| Statin | 32 (64) | 12 (60) |
| Antianginal drug | 16 (32) | 2 (10) |
The data are presented as mean ± SD. CAD: coronary artery disease; ACS: acute coronary syndrome; BP: blood pressure; TC: total cholesterol; TG: triglycerides; LDL: low-density lipoprotein; HDL: high-density lipoprotein; Hb: hemoglobin; Hs-CRP: high-sensitivity C-reactive protein; BNP: brain natriuretic peptide; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker. ∗ P < 0.05.